本科生同时使用苯丙胺类兴奋剂和抗抑郁药的情况。
Concurrent use of amphetamine stimulants and antidepressants by undergraduate students.
作者信息
Vo Kim, Neafsey Patricia J, Lin Carolyn A
机构信息
University of Connecticut Health Center, Farmington, CT, USA.
School of Nursing and Center for Health Information and Prevention, University of Connecticut, Storrs, CT, USA.
出版信息
Patient Prefer Adherence. 2015 Jan 22;9:161-72. doi: 10.2147/PPA.S74602. eCollection 2015.
Undergraduate students were recruited to participate in an online survey to report their use of amphetamine stimulants and other drugs. Significant differences were found between students reporting (n=79; 4.0%) and not reporting (n=1,897; 96%) amphetamine-stimulant use in the past month - in terms of race/ethnicity, class standing, residence, health symptoms, self-health report - in addition to alcohol, tobacco, pain-reliever, and antidepressant use. Health symptoms reported more often by stimulant users included depression, diarrhea, difficulty sleeping, fatigue, dizziness, difficulty concentrating, and nicotine craving. Health care providers of college students should query these patients about symptoms that could be related to depression and amphetamine use. In particular, they should provide education at the point of care around the risks of amphetamine use in general and the specific risks in those students who have symptoms of depression and/or are taking antidepressant medication. Prevention programs should also target the risks of concurrent use of amphetamines, antidepressants, and other drugs among college students.
招募本科生参与一项在线调查，以报告他们使用苯丙胺类兴奋剂和其他药物的情况。在过去一个月内报告使用过苯丙胺类兴奋剂（n = 79；4.0%）和未报告使用过（n = 1,897；96%）的学生之间，除了酒精、烟草、止痛药和抗抑郁药的使用情况外，在种族/民族、年级排名、居住情况、健康症状、自我健康报告方面发现了显著差异。兴奋剂使用者更常报告的健康症状包括抑郁、腹泻、睡眠困难、疲劳、头晕、注意力不集中和渴望尼古丁。大学生的医疗保健提供者应该询问这些患者可能与抑郁和使用苯丙胺有关的症状。特别是，他们应该在护理点提供关于一般使用苯丙胺的风险以及那些有抑郁症状和/或正在服用抗抑郁药物的学生的特定风险的教育。预防项目也应该针对大学生中同时使用苯丙胺、抗抑郁药和其他药物的风险。
Zotero 插件